BioPlay: Xoma Ltd.

Traders Blog | Monday 8 June 2009

Shares of Xoma Ltd. (Nasdaq:XOMA) closed up 38% Thursday, a gain analysts pinned on anticipation that the drug company will release positive data on its Type II diabetes treatment during a presentation this weekend.

In research notes Thursday, analysts said the new Phase I data on the drug, XOMA 052, should be strong since Xoma released positive initial Phase I results for the treatment in September. The presentation will be made at the American Diabetes Association conference in New Orleans on Saturday.

Strong Uptrend
XOMA LTD (NASDAQ:XOMA)
Smart Scan Chart Analysis continues positive longer term. Look for this market to remain firm. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.

FREE Trend analysis for XOMA Here

sc2

Investors get a FREE realtime analysis sent to your in-box by entering XOMA below!

Comment on this post below.

Via RSS

Via Twitter

Live Market Quotes

DJIA	10320.10	+50.63
NASDAQ	2200.01	+0.00
S&P 500	1090.10	+0.00
INTC	18.28	+0.00
CSCO	20.52	+0.00
FAS	20.39	+0.00
IWM	63.20	+0.00
GOOG	463.18	+0.00
MSFT	23.94	+0.00
EWJ	9.61	+0.00
NOVL	5.84	+0.00
SPY	109.47	+0.00
FAZ	14.50	+0.00
F	11.71	+0.00
PFE	16.40	+0.00
JPM	38.16	+0.00

2010-09-02 16:02

BioPlay: Xoma Ltd.

Comment on this post below.

Recent Posts

Most Viewed

Most Commented